Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection

NCT01900015 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER_GOV

Sponsor class

Conditions

HCV Coinfection
HIV Infection

Interventions

DRUG: Raltegravir
DRUG: Efavirenz

Sponsor

Juan Macías